These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20854406)

  • 21. The influence of measurement conditions on the Hammett acidity function of solid pharmaceutical excipients.
    Zinchuk AV; Hancock BC; Shalaev EY; Reddy RD; Govindarajan R; Novak E
    Eur J Pharm Biopharm; 2005 Oct; 61(3):158-70. PubMed ID: 16005194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties.
    Foldvari M; Bagonluri M
    Nanomedicine; 2008 Sep; 4(3):173-82. PubMed ID: 18550451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.
    Alhusban F; Perrie Y; Mohammed AR
    Eur J Pharm Biopharm; 2011 Nov; 79(3):627-34. PubMed ID: 21693189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive stratum corneum sampling and electron microscopical examination of skin barrier integrity: pilot study with a topical glycerin formulation for atopic dermatitis.
    Daehnhardt-Pfeiffer S; Surber C; Wilhelm KP; Daehnhardt D; Springmann G; Boettcher M; Foelster-Holst R
    Skin Pharmacol Physiol; 2012; 25(3):155-61. PubMed ID: 22399038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Déjà vu all over again: skin cap still contains a high-potency glucocorticosteroid.
    Swanson DL; Pittelkow MR; Benson LM; Hawkridge AM; Muddiman DC
    Arch Dermatol; 2005 Jun; 141(6):801-3. PubMed ID: 15967944
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glucocorticoid containing extemporaneous formulations. Rational for use in dermatology].
    Högger P
    Pharm Unserer Zeit; 2010 Jul; 39(4):294-9. PubMed ID: 20589803
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Excipients influence on properites of thermosensitive carriers containing methotrexate].
    Karolewicz B; Pluta J
    Polim Med; 2008; 38(3):3-15. PubMed ID: 19137972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Suggestions for improving quality control of excipients used in processing of crude drugs].
    Zhao Y
    Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(22):3084-5. PubMed ID: 21355288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Natural biopolymers as excipients in medicinal product dosage form. Part I. Soft gelatin capsules as a modern and elegant pharmaceutical dosage form].
    Dobrzyński ŁJ; Zgoda MM
    Polim Med; 2010; 40(2):11-9. PubMed ID: 20649085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Polymers as excipients used in the technology of coated tablets containing ibandronic acid derivatives (bisphosphonates)].
    Kołodziejczyk MK; Zgoda MM
    Polim Med; 2012; 42(1):5-16. PubMed ID: 22783728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
    Wilson AG; Nouraldeen A; Gopinathan S
    Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium sulphate dihydrate: an useful excipient for tablets containing labile actives.
    Eyjolfsson R
    Pharmazie; 2004 Sep; 59(9):725-6. PubMed ID: 15497759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and statistical optimization of osmotically driven capsule based on push-pull technology.
    Shaikh W; Deshmukh PK; Patil GB; Chatap VK; Bari SB
    Pharm Dev Technol; 2013; 18(2):515-24. PubMed ID: 23033881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of new biological therapy in psoriasis treatment].
    Cortijo Cascajares S; García Rodríguez MP; Campo Angora M; Serrano Garrote O; Herreros de Tejada A
    Farm Hosp; 2004; 28(3):192-200. PubMed ID: 15222873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alefacept treatment for chronic plaque psoriasis.
    Dunn LK; Feldman SR
    Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis treatment: traditional therapy.
    Lebwohl M; Ting PT; Koo JY
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii83-6. PubMed ID: 15708945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.